What Happened to Oklo Inc.?

Oklo Inc., an advanced nuclear technology company, has been on a dynamic trajectory, aiming to revolutionize the energy sector with its fast fission power plants, including microreactors, and capabilities in isotope production and nuclear fuel recycling. The company's journey to public markets began with an announcement in July 2023 of its plan to merge with AltC Acquisition Corp., a special purpose acquisition company (SPAC) led by Sam Altman, valuing Oklo at $850 million. This merger was successfully completed on May 9, 2024, with Oklo's common stock commencing trading on the NYSE under the ticker 'OKLO' on May 10, 2024, bringing in approximately $306 million in gross proceeds to fund its business plan.

A key turning point for Oklo occurred in January 2022 when its initial combined license application for the Aurora reactor was denied by the U.S. Nuclear Regulatory Commission (NRC) due to insufficient information. Following this, Oklo shifted its strategy, focusing on closer collaboration with the U.S. Department of Energy (DOE) and pursuing a 'learn-first-then-scale' approach. This strategy has led to a series of significant regulatory and operational milestones. In September 2024, Oklo finalized a Memorandum of Agreement with the DOE Idaho Operations Office, granting access for site investigations at its preferred Idaho site. By September 2025, Oklo broke ground on its first Aurora powerhouse at Idaho National Laboratory (INL), a sodium-cooled fast reactor designed to provide 75 MWe, under the DOE's Reactor Pilot Program.

The company's momentum accelerated into 2026 with several crucial developments. In January 2026, Oklo announced a significant agreement with Meta to develop a 1.2 gigawatt nuclear power campus in Pike County, Ohio, to support Meta's data centers, with Meta providing prepayment to fund construction. This partnership highlights the growing demand for reliable, clean energy from the artificial intelligence sector. Also in January 2026, Oklo signed an Other Transaction Agreement with the DOE to support the design, construction, and operation of a radioisotope pilot plant, to be operated by its subsidiary Atomic Alchemy Inc., aiming to establish domestic production of critical medical and research isotopes.

March 2026 saw a flurry of regulatory successes. Oklo announced the DOE's approval of the Nuclear Safety Design Agreement (NSDA) for its Aurora powerhouse at INL, a critical step under the DOE's Reactor Pilot Program. Concurrently, Oklo's Atomic Alchemy subsidiary received its first-ever materials license from the NRC, authorizing it to handle, process, and distribute isotopes from its Idaho Radiochemistry Laboratory, with the expectation of generating its first revenue in 2026 from this facility. Furthermore, in late March 2026, Oklo expanded its partnership with Sweden's Blykalla AB to collaborate on fast reactor commercialization, involving potential U.S. investments and engineering support.

Financially, Oklo reported its full-year 2025 results on March 17, 2026, showing an operating loss of $139.3 million, typical for a pre-revenue development-stage company, but ending the year with $1.4 billion in cash and marketable securities. In early 2026, the company raised an additional $1.18 billion, completing its $1.5 billion ATM program, bolstering its liquidity to approximately $2.6 billion. Despite a significant stock rally in 2025, OKLO shares experienced a correction in early 2026, with analysts adjusting price targets while maintaining a generally positive outlook, citing the company's strong financial position and strategic partnerships. As of April 15, 2026, Oklo is nearing a critical milestone, with its first reactor expected to reach operational criticality by July 4, 2026, under a federal pilot program, marking a pivotal step towards commercialization.